JP2015531789A5 - - Google Patents

Download PDF

Info

Publication number
JP2015531789A5
JP2015531789A5 JP2015532458A JP2015532458A JP2015531789A5 JP 2015531789 A5 JP2015531789 A5 JP 2015531789A5 JP 2015532458 A JP2015532458 A JP 2015532458A JP 2015532458 A JP2015532458 A JP 2015532458A JP 2015531789 A5 JP2015531789 A5 JP 2015531789A5
Authority
JP
Japan
Prior art keywords
pyrrolysine
mutein
unnatural amino
conjugated
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015532458A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015531789A (ja
JP6321658B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/069888 external-priority patent/WO2014044873A1/en
Publication of JP2015531789A publication Critical patent/JP2015531789A/ja
Publication of JP2015531789A5 publication Critical patent/JP2015531789A5/ja
Application granted granted Critical
Publication of JP6321658B2 publication Critical patent/JP6321658B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015532458A 2012-09-24 2013-09-24 アミノ酸誘導体 Expired - Fee Related JP6321658B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261705116P 2012-09-24 2012-09-24
US61/705,116 2012-09-24
US201361862495P 2013-08-05 2013-08-05
US61/862,495 2013-08-05
PCT/EP2013/069888 WO2014044873A1 (en) 2012-09-24 2013-09-24 Amino acid derivatives

Publications (3)

Publication Number Publication Date
JP2015531789A JP2015531789A (ja) 2015-11-05
JP2015531789A5 true JP2015531789A5 (enExample) 2018-03-29
JP6321658B2 JP6321658B2 (ja) 2018-05-09

Family

ID=49237211

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015532457A Active JP6532404B2 (ja) 2012-09-24 2013-09-24 細胞株
JP2015532458A Expired - Fee Related JP6321658B2 (ja) 2012-09-24 2013-09-24 アミノ酸誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015532457A Active JP6532404B2 (ja) 2012-09-24 2013-09-24 細胞株

Country Status (10)

Country Link
US (4) US9670521B2 (enExample)
EP (2) EP2897935B1 (enExample)
JP (2) JP6532404B2 (enExample)
KR (1) KR102155389B1 (enExample)
CN (2) CN105026574B (enExample)
AU (1) AU2013320184B2 (enExample)
BR (1) BR112015006368B1 (enExample)
CA (1) CA2885796C (enExample)
SG (2) SG11201502216UA (enExample)
WO (2) WO2014044873A1 (enExample)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012088381A2 (en) 2010-12-22 2012-06-28 President And Fellows Of Harvard College Continuous directed evolution
US20150148525A1 (en) 2012-05-18 2015-05-28 Medical Research Council Methods of incorporating an amino acid comprising a bcn group into a polypeptide using an orthogonal codon encoding it and an orthorgonal pylrs synthase
CN104583235B (zh) 2012-06-08 2019-03-01 苏特罗生物制药公司 含位点特异非天然氨基酸残基的抗体、其制备和使用方法
US9732161B2 (en) 2012-06-26 2017-08-15 Sutro Biopharma, Inc. Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
WO2014044873A1 (en) 2012-09-24 2014-03-27 Allozyne, Inc Amino acid derivatives
SG11201507104WA (en) 2013-03-15 2015-10-29 Medimmune Ltd Novel nucleic acid molecules
ES2865473T3 (es) * 2013-07-10 2021-10-15 Sutro Biopharma Inc Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso
US9981908B2 (en) 2013-08-05 2018-05-29 Medimmune Limited Amino acid derivatives
JP6564369B2 (ja) 2013-12-09 2019-08-21 デュレクト コーポレイション 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
WO2015134121A2 (en) 2014-01-20 2015-09-11 President And Fellows Of Harvard College Negative selection and stringency modulation in continuous evolution systems
GB2528227A (en) * 2014-03-14 2016-01-20 Medical Res Council Cyclopropene amino acids and methods
US10920208B2 (en) 2014-10-22 2021-02-16 President And Fellows Of Harvard College Evolution of proteases
RU2708459C2 (ru) 2014-10-29 2019-12-09 БайсиклРД Лимитед Бициклические пептидные лиганды, специфичные для мт1-ммр
CN106146663B (zh) * 2015-04-10 2019-11-08 北京大学 非天然氨基酸标记的新型抗体-药物偶联物及其制备
WO2016168631A1 (en) 2015-04-17 2016-10-20 President And Fellows Of Harvard College Vector-based mutagenesis system
US10392674B2 (en) 2015-07-22 2019-08-27 President And Fellows Of Harvard College Evolution of site-specific recombinases
WO2017015559A2 (en) 2015-07-23 2017-01-26 President And Fellows Of Harvard College Evolution of bt toxins
US10612011B2 (en) 2015-07-30 2020-04-07 President And Fellows Of Harvard College Evolution of TALENs
JP6967221B2 (ja) * 2015-08-19 2021-11-17 国立研究開発法人理化学研究所 非天然アミノ酸導入抗体
IL294014B2 (en) 2015-10-23 2024-07-01 Harvard College Nucleobase editors and uses thereof
CN106929482A (zh) * 2015-12-31 2017-07-07 北京大学 定点突变的流感病毒、其活疫苗及其制备方法和应用
CN112725282A (zh) * 2016-01-27 2021-04-30 北京大学 携带正交tRNA/氨酰tRNA合成酶的稳定细胞系的构建
KR20180104106A (ko) 2016-01-27 2018-09-19 서트로 바이오파마, 인크. anti-CD74 항체 접합체, anti-CD74 항체 접합체를 포함하는 조성물 및 anti-CD74 항체 접합체의 이용 방법
CN105524167A (zh) * 2016-01-30 2016-04-27 深圳市贝沃德克生物技术研究院有限公司 抗乙肝e抗原的绿色荧光抗体的制备方法
CN105647918A (zh) * 2016-02-20 2016-06-08 深圳市圣必智科技开发有限公司 抗乙肝e抗原的红色荧光抗体的制备方法
CA3028134A1 (en) 2016-06-17 2017-12-21 Magenta Therapeutics, Inc. Compositions and methods for the depletion of cd117+ cells
US11214820B2 (en) * 2016-09-02 2022-01-04 Ikaria Inc. Functionally modified polypeptides and radiobiosynthesis
KR102013742B1 (ko) * 2016-09-05 2019-11-04 한국과학기술원 목적 단백질의 위치 특이적 변형이 시공간적으로 조절되는 마우스, 이의 제조방법 및 그 용도
WO2018044143A1 (ko) * 2016-09-05 2018-03-08 한국과학기술원 목적 단백질의 위치 특이적 변형이 시공간적으로 조절되는 마우스, 이의 제조방법 및 그 용도
US11730819B2 (en) 2016-12-23 2023-08-22 Bicycletx Limited Peptide derivatives having novel linkage structures
SG10202102897PA (en) 2017-01-20 2021-04-29 Magenta Therapeutics Inc Compositions and methods for the depletion of cd137+ cells
US11447809B2 (en) 2017-07-06 2022-09-20 President And Fellows Of Harvard College Evolution of tRNA synthetases
EP3661948B1 (en) 2017-08-04 2022-06-01 BicycleTx Limited Bicyclic peptide ligands specific for cd137
US12060553B2 (en) 2017-08-25 2024-08-13 President And Fellows Of Harvard College Evolution of BoNT peptidases
WO2019056002A1 (en) 2017-09-18 2019-03-21 President And Fellows Of Harvard College CONTINUOUS EVOLUTION FOR STABILIZED PROTEINS
EP3733693A4 (en) 2017-12-27 2021-12-22 Kyowa Kirin Co., Ltd. IL-2 VARIANT
EP3755725A1 (en) 2018-02-23 2020-12-30 BicycleTX Limited Multimeric bicyclic peptide ligands
WO2019241649A1 (en) 2018-06-14 2019-12-19 President And Fellows Of Harvard College Evolution of cytidine deaminases
IL279489B2 (en) 2018-06-22 2025-10-01 Bicycletx Ltd Bicyclic peptide ligands specific for nectin-4, a drug conjugate containing the peptide ligands and a pharmaceutical composition containing the drug conjugate
CN110835633B (zh) * 2018-08-13 2021-10-01 北京大学 利用优化的基因密码子扩展系统制备ptc稳定细胞系及应用
JP2021536263A (ja) * 2018-09-07 2021-12-27 メディミューン,エルエルシー 細胞選択の方法
GB201817444D0 (en) 2018-10-26 2018-12-12 Res & Innovation Uk Methods and compositions
CN109553643B (zh) * 2018-11-29 2020-09-22 深圳先进技术研究院 单糖类似物及包含其的分子探针和该分子探针的应用
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
JP2022514618A (ja) 2018-12-21 2022-02-14 バイスクルテクス・リミテッド Pd-l1に特異的な二環式ペプチドリガンド
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
CN111850020B (zh) * 2019-04-25 2021-05-07 苏州鲲鹏生物技术有限公司 利用质粒系统在蛋白中引入非天然氨基酸
CN111909256A (zh) * 2019-05-10 2020-11-10 宁波鲲鹏生物科技有限公司 多肽衍生物及其制备方法
TWI862640B (zh) 2019-07-30 2024-11-21 英商拜西可泰克斯有限公司 異質雙環肽複合物
IL292440A (en) * 2019-10-23 2022-06-01 Univ Florida Novel conjugation chemistry for catalytic antibody 38c2
EP4210725A4 (en) * 2020-09-10 2025-01-01 Brickbio, Inc. ANTIBODIES WITH UNNATURAL AMINO ACIDS AND METHODS FOR THE PRODUCTION AND USE THEREOF
KR20240019759A (ko) * 2021-04-21 2024-02-14 아시모브 인코포레이티드 아데노-연관 바이러스 생산을 위한 안정적인 생산 시스템
WO2022232377A2 (en) * 2021-04-28 2022-11-03 The Regents Of The University Of California Bioreactive proteins containing unnatural amino acids
WO2023004686A1 (zh) * 2021-07-29 2023-02-02 浙江新码生物医药有限公司 一种非天然氨基酸及其应用、包含其的重组蛋白以及重组蛋白偶联物
EP4130254A1 (en) * 2021-08-03 2023-02-08 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Eukaryotic cell lysates comprising exogenous enzymes and methods for preparing the same
CN113698468B (zh) * 2021-09-01 2022-10-11 浙江新码生物医药有限公司 人白细胞介素2-聚乙二醇偶联物及其应用
CN113788890B (zh) * 2021-09-01 2022-11-08 浙江新码生物医药有限公司 一种人白细胞介素2-聚乙二醇偶联物及其应用
WO2023164676A1 (en) * 2022-02-27 2023-08-31 The Regents Of The University Of California Methods to generate novel acyl-trna species
WO2024223923A1 (en) * 2023-04-28 2024-10-31 United Kingdom Research And Innovation tRNA-BASED METHODS AND RELATED COMPOSITIONS
WO2025011557A1 (en) * 2023-07-10 2025-01-16 Surio Therapeutics Co. Ltd Functionalized auristatins, pharmaceutical compositions, and therapeutic applications

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711458A (en) 1969-08-21 1973-01-16 Research Corp Substituted and unsubstituted vinyloxycarbonyl groups as amino protecting groups in the syntheses of peptides
US4512979A (en) 1981-03-23 1985-04-23 Merck & Co., Inc. Dipeptides containing thialysine and related amino acids as antihypertensives
JPH0710451B2 (ja) 1986-11-25 1995-02-08 三五重機株式会社 鋼板カツタ−
HU207287B (en) 1989-01-17 1993-03-29 Biosignal Kutato Fejlesztoe Kf Polyene fatty acid derivatives of tyrozine-quinaze inhibiting activity and pharmaceutical composition containing them as active component
US5180674A (en) 1990-04-16 1993-01-19 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
IL158418A0 (en) 2001-04-19 2004-05-12 Scripps Research Inst In vivo incorporation of unnatural amino acids
EP2305313B1 (en) 2001-10-10 2014-03-26 ratiopharm GmbH Remodelling and glycoconjugation of interferon-alpha (IFNa)
JP4752001B2 (ja) 2002-10-16 2011-08-17 ザ スクリプス リサーチ インスティチュート 糖蛋白質合成
US20040146941A1 (en) * 2002-11-04 2004-07-29 Biliang Zhang Chemical encoding technology for combinatorial synthesis
US7618775B2 (en) * 2003-04-17 2009-11-17 The Scripps Research Institute Expanding the eukaryotic genetic code
PT1812031E (pt) 2004-11-01 2015-10-01 Univ California Composições e métodos para modificação de biomoléculas
JP2007037445A (ja) * 2005-08-02 2007-02-15 Institute Of Physical & Chemical Research tRNA合成方法、核酸、アミノアシルtRNA合成方法及び非天然型アミノ酸組み込み蛋白質の製造方法
EP1992698B1 (en) 2006-02-22 2018-09-05 Riken METHOD FOR SYNTHESIS OF SUPPRESSOR tRNA, DNA CONSTRUCT, AND PRODUCTION OF PROTEIN HAVING NON-NATURAL AMINO ACID INTEGRATED THEREIN BY USING THE DNA CONSTRUCT
US7632492B2 (en) 2006-05-02 2009-12-15 Allozyne, Inc. Modified human interferon-β polypeptides
CA2665678A1 (en) * 2006-10-18 2008-06-19 The Scripps Research Institute Genetic incorporation of unnatural amino acids into proteins in mammalian cells
CA2706889C (en) 2007-09-20 2018-08-28 Riken Mutant pyrrolysyl-trna synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same
WO2010008110A1 (en) 2008-07-18 2010-01-21 Alantum Corporation Filter device for filtering automobile exhaust gas
JP5798489B2 (ja) 2009-01-12 2015-10-21 ストロ バイオファーマ, インコーポレイテッド インビトロタンパク質合成システムを用いて非天然アミノ酸をタンパク質に選択的に導入するためのモノチャージシステム
US20100203587A1 (en) 2009-01-13 2010-08-12 Sutro Biopharma, Inc. Use of dna gyrase inhibitors for in vitro polypeptide synthesis reactions
WO2010114615A2 (en) 2009-04-03 2010-10-07 The Scripps Research Institute A facile system for encoding unnatural amino acids in mammalian cells
GB2470770A (en) 2009-06-04 2010-12-08 Medical Res Council Incorporation of unnatural amino acids having an orthogonal functional group into polypeptides using orthogonal tRNA/tRNA synthetase pairs
US8921571B2 (en) 2009-10-06 2014-12-30 The Ohio State University Pyrrolysine analogs
AU2010341516B2 (en) * 2009-12-21 2014-01-16 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
NZ600363A (en) 2009-12-21 2014-07-25 Ambrx Inc Modified porcine somatotropin polypeptides and their uses
PL2563753T6 (pl) 2010-04-27 2016-05-31 Synaffix Bv Stopione związki cyklooktynu i ich zastosowanie w reakcjach typu "click" bez udziału metalu
EP2640745B1 (en) * 2010-09-10 2018-11-07 MedImmune Limited Bivalent and bispecific anti-il6/anti-il23 antibodies
DE102010041261A1 (de) * 2010-09-23 2012-03-29 Robert Bosch Gmbh Flip-Chip Anordnung mit einem Kühlelement und Verfahren zur Herstellung einer Flip-Chip Anordnung
EP2619305A1 (en) * 2010-09-24 2013-07-31 Medical Research Council Methods for incorporating unnatural amino acids in eukaryotic cells
CA2826041C (en) * 2011-02-03 2020-07-07 Embl Unnatural amino acids comprising a cyclooctynyl or trans-cyclooctenyl analog group and uses thereof
SG11201501464TA (en) 2012-08-31 2015-03-30 Sutro Biopharma Inc Modified amino acids comprising an azido group
WO2014044873A1 (en) 2012-09-24 2014-03-27 Allozyne, Inc Amino acid derivatives
SG11201507104WA (en) 2013-03-15 2015-10-29 Medimmune Ltd Novel nucleic acid molecules

Similar Documents

Publication Publication Date Title
JP2015531789A5 (enExample)
EP4410317A3 (en) Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
JP2015532295A5 (enExample)
JP2020097577A5 (enExample)
JP2016153410A5 (enExample)
JP2009523724A5 (enExample)
JP2016106149A5 (enExample)
JP2010521485A5 (enExample)
JP2012518029A5 (enExample)
JP2019524883A5 (enExample)
JP2016531842A5 (enExample)
JP2020507589A5 (enExample)
JP2017515901A5 (enExample)
JP2016531871A5 (enExample)
JP2013518107A5 (enExample)
JP2010077141A5 (enExample)
JP2013508279A5 (enExample)
JP2017531619A5 (enExample)
JP2011517683A5 (enExample)
JP2010500962A5 (enExample)
JP2020529994A5 (enExample)
JP2019516739A5 (enExample)
JP2003306481A5 (enExample)
JP2019510027A5 (enExample)
JP2015508092A5 (enExample)